ProfileGDS4718 / 220283_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 44% 49% 52% 45% 42% 45% 56% 43% 46% 42% 38% 45% 41% 44% 48% 43% 42% 44% 46% 48% 47% 42% 44% 48% 41% 48% 44% 34% 44% 44% 41% 50% 49% 42% 39% 43% 42% 45% 44% 48% 45% 42% 39% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1052942
GSM549102patient 115, normal, homogenized [OPG study]5.2392944
GSM549104patient 119, normal, homogenized [OPG study]5.4381349
GSM549108patient 138, normal, homogenized [OPG study]5.6403152
GSM549119patient 077, normal, homogenized [OPG study]5.2782245
GSM549133patient 032, cancer, homogenized [OPG study]5.0210442
GSM549139patient 042, cancer, homogenized [OPG study]5.2051945
GSM549099patient 107, normal, homogenized [OPG study]5.845456
GSM549109patient 139, normal, homogenized [OPG study]5.1745343
GSM549110patient 046, normal, homogenized [OPG study]5.2666146
GSM549114patient 063, normal, homogenized [OPG study]5.0626242
GSM549122patient 082, normal, homogenized [OPG study]4.9182938
GSM549134patient 033, cancer, homogenized [OPG study]5.2169645
GSM549136patient 036, cancer, homogenized [OPG study]4.9891641
GSM549140patient 044, cancer, homogenized [OPG study]5.157244
GSM549111patient 047, normal, homogenized [OPG study]5.3901148
GSM549113patient 057, normal, homogenized [OPG study]5.0790443
GSM549132patient 031, cancer, homogenized [OPG study]5.090742
GSM549137patient 038, cancer, homogenized [OPG study]5.1684644
GSM549142patient 047, cancer, homogenized [OPG study]5.4001346
GSM549100patient 110, normal, homogenized [OPG study]5.4096448
GSM549107patient 135, normal, homogenized [OPG study]5.3189447
GSM549115patient 068, normal, homogenized [OPG study]5.0293542
GSM549116patient 072, normal, homogenized [OPG study]5.1646144
GSM549120patient 078, normal, homogenized [OPG study]5.4029648
GSM549131patient 030, cancer, homogenized [OPG study]4.9915141
GSM549118patient 074, normal, homogenized [OPG study]5.4257248
GSM549129patient 027, cancer, homogenized [OPG study]5.1964844
GSM549123patient 088, normal, homogenized [OPG study]4.7140634
GSM549124patient 006, cancer, homogenized [OPG study]5.2103444
GSM549126patient 015, cancer, homogenized [OPG study]5.1777644
GSM549128patient 025, cancer, homogenized [OPG study]4.9959941
GSM549103patient 117, normal, homogenized [OPG study]5.5735850
GSM549117patient 073, normal, homogenized [OPG study]5.4076449
GSM549138patient 041, cancer, homogenized [OPG study]5.058142
GSM549141patient 045, cancer, homogenized [OPG study]4.8720539
GSM549130patient 028, cancer, homogenized [OPG study]5.1444343
GSM549101patient 111, normal, homogenized [OPG study]5.1130142
GSM549105patient 128, normal, homogenized [OPG study]5.2816345
GSM549106patient 134, normal, homogenized [OPG study]5.1498744
GSM549112patient 048, normal, homogenized [OPG study]5.3658448
GSM549125patient 011, cancer, homogenized [OPG study]5.2643445
GSM549127patient 024, cancer, homogenized [OPG study]5.1052942
GSM549135patient 035, cancer, homogenized [OPG study]4.8929639